Correlation Between Nuvectis Pharma and Nurix Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Nurix Therapeutics, you can compare the effects of market volatilities on Nuvectis Pharma and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Nurix Therapeutics.

Diversification Opportunities for Nuvectis Pharma and Nurix Therapeutics

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nuvectis and Nurix is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Nurix Therapeutics

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 1.5 times more return on investment than Nurix Therapeutics. However, Nuvectis Pharma is 1.5 times more volatile than Nurix Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  458.00  in Nuvectis Pharma on December 22, 2024 and sell it today you would earn a total of  562.00  from holding Nuvectis Pharma or generate 122.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  Nurix Therapeutics

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvectis Pharma are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting fundamental indicators, Nuvectis Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Nurix Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nuvectis Pharma and Nurix Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Nurix Therapeutics

The main advantage of trading using opposite Nuvectis Pharma and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.
The idea behind Nuvectis Pharma and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance